Literature DB >> 24262186

The functional role of beta oscillations in Parkinson's disease.

Simon Little1, Peter Brown.   

Abstract

Modulations of beta oscillations (13-30 Hz) during normal motor control suggest that they may act to promote current motor set at the expense of new movements. These oscillations are greatly enhanced in Parkinson's disease (PD) and there is strong correlative evidence linking beta activity at rest and beta changes in response to treatment with bradykinesia and rigidity. Some evidence that this link may be mechanistically important or causal comes from studies in which either cortical or subcortical sites have been stimulated in the beta frequency range causing modest but significant slowing of movements. However, recent trials in which high frequency deep brain stimulation (DBS) has only been delivered during periods of elevated beta activity have demonstrated major clinical effects that even exceed those of standard continuous high frequency DBS. These studies suggest that beta activity may be both causally and quantitatively important in the motor impairment of PD, and demonstrate how improvements in the understanding of the pathophysiology of PD can lead to enhanced therapeutic interventions in this condition.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Beta oscillations; Deep brain stimulation; Parkinson's disease

Mesh:

Year:  2014        PMID: 24262186     DOI: 10.1016/S1353-8020(13)70013-0

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  84 in total

1.  The beta oscillation conditions in a simplified basal ganglia network.

Authors:  Bing Hu; Xiyezi Diao; Heng Guo; Shasha Deng; Yu Shi; Yuqi Deng; Liqing Zong
Journal:  Cogn Neurodyn       Date:  2018-12-04       Impact factor: 5.082

2.  Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit.

Authors:  Jackson N Cagle; Michael S Okun; Enrico Opri; Stephanie Cernera; Rene Molina; Kelly D Foote; Aysegul Gunduz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-05       Impact factor: 10.154

Review 3.  Physiological Markers of Motor Inhibition during Human Behavior.

Authors:  Julie Duque; Ian Greenhouse; Ludovica Labruna; Richard B Ivry
Journal:  Trends Neurosci       Date:  2017-03-21       Impact factor: 13.837

4.  Pallidal deep brain stimulation modulates excessive cortical high β phase amplitude coupling in Parkinson disease.

Authors:  Mahsa Malekmohammadi; Nicholas AuYong; Joni Ricks-Oddie; Yvette Bordelon; Nader Pouratian
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

Review 5.  When brain rhythms aren't 'rhythmic': implication for their mechanisms and meaning.

Authors:  Stephanie R Jones
Journal:  Curr Opin Neurobiol       Date:  2016-07-09       Impact factor: 6.627

Review 6.  Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation.

Authors:  Cameron C McIntyre; Ross W Anderson
Journal:  J Neurochem       Date:  2016-06-08       Impact factor: 5.372

7.  Pallidal low β-low γ phase-amplitude coupling inversely correlates with Parkinson disease symptoms.

Authors:  Christos Tsiokos; Mahsa Malekmohammadi; Nicholas AuYong; Nader Pouratian
Journal:  Clin Neurophysiol       Date:  2017-09-05       Impact factor: 3.708

8.  β-Bursts Reveal the Trial-to-Trial Dynamics of Movement Initiation and Cancellation.

Authors:  Jan R Wessel
Journal:  J Neurosci       Date:  2019-11-20       Impact factor: 6.167

9.  Parvalbumin+ and Npas1+ Pallidal Neurons Have Distinct Circuit Topology and Function.

Authors:  Arin Pamukcu; Qiaoling Cui; Harry S Xenias; Brianna L Berceau; Elizabeth C Augustine; Isabel Fan; Saivasudha Chalasani; Adam W Hantman; Talia N Lerner; Simina M Boca; C Savio Chan
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

10.  Neural mechanisms of transient neocortical beta rhythms: Converging evidence from humans, computational modeling, monkeys, and mice.

Authors:  Maxwell A Sherman; Shane Lee; Robert Law; Saskia Haegens; Catherine A Thorn; Matti S Hämäläinen; Christopher I Moore; Stephanie R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.